Wilson - ABSORB - Carilion Clinic

Dept. of Research & Development
[email protected]
540-985-8510
Clinical Trial Website Request
The Principal Investigator or his/her designee is responsible for completing this form when a new clinical trial
needs to be added to the external website: http://www.carilionclinic.org/research/clinical-trials-virginia. Be sure to
use lay language and avoid too much detail. All sections are required so any incomplete forms will be returned.
The Dept. of Research & Development and Strategic Development retain the right to edit or modify any
information that is submitted for publication. Please email form to R&D ([email protected]) and allow 5
business days for the information to post to the website.
Information
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable
Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery
Lesions.
Project Title (full)
Project Title (abbreviated
– limit 100 characters
Principal Investigator
Contact to be listed
The ABSORB trial
Gary Swank MD
Name:
Telephone
IRB Approved?
Yes
No
Department R & D
Vivian Wilson RN
540-632-9852
Clinical Research
Nurse/Coordinator
Email [email protected]
Title
Division
Interventional Cariology
Description
Protocol Description
(limit 200 words)
Eligibility Criteria
The trial is called ABSORB IV Randomized Controlled Trial, which is a clinical
evaluation of Absorb™ Bioresorbable Vascular Scaffold (BVS) in the treatment of
subjects with de novo native coronary artery lesions. ABSORB IV is currently
enrolling subjects who have evidence of myocardial ischemia suitable for PCI.
The primary objective of this study is to assess the safety and effectiveness of the
Absorb BVS compared with the XIENCE family stent systems (XIENCE Alpine,
XIENCE V, XIENCE PRIME, and XIENCE Xpedition) for the treatment of patients
with ischemic heart disease. ABSORB IV is a prospective, randomized (1:1 Absorb
BVS to XIENCE), single-blind, multi-center trial, registering approximately 3,000
subjects.
Adult patients with documented coronary artery disease that have 1-3 native coronary
artery lesions (blockages) that meet the angiographic criteria for the trial.
Publish Dates
Date to start displaying content
Date to archive content
Immediately
N/A
Additional Information
Would you like to add directions to your office?
Yes
No If yes, provide directions below:
1/2
Version date 3/2013
Extramural Proposals
Dept. of Research & Development
[email protected]
Would you like to add a photo to this page?
Yes
No If yes, provide photo when submitting or link below:
Is there a link, like clinicaltrials.gov, that you would like to add?
Yes
https://clinicaltrials.gov/ct2/show/NCT02173379?term=absorb&rank=10
No If yes, provide the link below:
Version date 3/2013
2/2